<qa>  What is the name of the study that evaluated 3 doses of GSK573719 administeredThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate 3 doses of GSK573719 administered once-daily over 28 days in subjects with COPD. 